Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery

Drug resistance is a looming threat to global health security, undermining the effectiveness of current treatments and increasing treatment failures. To address this challenge, it is necessary to explore innovative strategies by identifying new binding mechanisms and targeting previously undeveloped...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaoqing Du, Xinyong Liu, Xueping Hu, Peng Zhan
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2025-03-01
Series:Pharmaceutical Fronts
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-2523-2174
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849393191915094016
author Shaoqing Du
Xinyong Liu
Xueping Hu
Peng Zhan
author_facet Shaoqing Du
Xinyong Liu
Xueping Hu
Peng Zhan
author_sort Shaoqing Du
collection DOAJ
description Drug resistance is a looming threat to global health security, undermining the effectiveness of current treatments and increasing treatment failures. To address this challenge, it is necessary to explore innovative strategies by identifying new binding mechanisms and targeting previously undeveloped therapeutic avenues. This paper reviewed the potential of leveraging undeveloped domains to combat drug resistance and proposes a range of methodologies to accurately identify those specific targets. There is also an extensive review of the challenges associated with targeting undeveloped areas and strategies to effectively address them. In this process, the application of artificial intelligence (AI) can effectively improve the efficiency of drug design, while appropriate attention should be paid to the physicochemical and drug-like properties of pharmaceutical compounds in the realm of drug discovery. Given the above, focusing on these undeveloped areas could provide a promising pathway to address drug resistance; however, achieving this objective necessitates sustained investigative efforts and inventive approaches.
format Article
id doaj-art-a26d5ba266014cdb9af856c8fd35a5e8
institution Kabale University
issn 2628-5088
2628-5096
language English
publishDate 2025-03-01
publisher Georg Thieme Verlag KG
record_format Article
series Pharmaceutical Fronts
spelling doaj-art-a26d5ba266014cdb9af856c8fd35a5e82025-08-20T03:40:30ZengGeorg Thieme Verlag KGPharmaceutical Fronts2628-50882628-50962025-03-010701e1e810.1055/a-2523-2174Undeveloped Region in Target-Strategies and Potential in Antiviral Drug DiscoveryShaoqing Du0Xinyong Liu1Xueping Hu2Peng Zhan3Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of ChinaDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of ChinaInstitute of Frontier Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Qingdao, People's Republic of ChinaDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of ChinaDrug resistance is a looming threat to global health security, undermining the effectiveness of current treatments and increasing treatment failures. To address this challenge, it is necessary to explore innovative strategies by identifying new binding mechanisms and targeting previously undeveloped therapeutic avenues. This paper reviewed the potential of leveraging undeveloped domains to combat drug resistance and proposes a range of methodologies to accurately identify those specific targets. There is also an extensive review of the challenges associated with targeting undeveloped areas and strategies to effectively address them. In this process, the application of artificial intelligence (AI) can effectively improve the efficiency of drug design, while appropriate attention should be paid to the physicochemical and drug-like properties of pharmaceutical compounds in the realm of drug discovery. Given the above, focusing on these undeveloped areas could provide a promising pathway to address drug resistance; however, achieving this objective necessitates sustained investigative efforts and inventive approaches.http://www.thieme-connect.de/DOI/DOI?10.1055/a-2523-2174drug resistancetargeting undeveloped sitesantiviral drug designtarget-based drug discovery
spellingShingle Shaoqing Du
Xinyong Liu
Xueping Hu
Peng Zhan
Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
Pharmaceutical Fronts
drug resistance
targeting undeveloped sites
antiviral drug design
target-based drug discovery
title Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
title_full Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
title_fullStr Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
title_full_unstemmed Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
title_short Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
title_sort undeveloped region in target strategies and potential in antiviral drug discovery
topic drug resistance
targeting undeveloped sites
antiviral drug design
target-based drug discovery
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-2523-2174
work_keys_str_mv AT shaoqingdu undevelopedregionintargetstrategiesandpotentialinantiviraldrugdiscovery
AT xinyongliu undevelopedregionintargetstrategiesandpotentialinantiviraldrugdiscovery
AT xuepinghu undevelopedregionintargetstrategiesandpotentialinantiviraldrugdiscovery
AT pengzhan undevelopedregionintargetstrategiesandpotentialinantiviraldrugdiscovery